ADENOBIO
DEAD

Serial Number

76595520

Owner

ADENOBIO N.V.

Attorney

IRA S. DORMAN

Filing Date

Jun 3, 2004

Add to watchlist:

No watchlists yet
View on USPTO

ADENOBIO Trademark

Serial Number: 76595520 • Registration: 3238587

ADENOBIO is a trademark filed by ADENOBIO N.V. on June 3, 2004. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

ADENOBIO N.V. (3 trademarks)

WTC SCHIPHOL AIRPORT, 8 TOWER, 5TH FLOOR
1118 BH AMSTERDAM SCHIPHOL , NL

Entity Type: 99

Adenobio B.V.

Burgemeester Haspelslaan 131
1181NC Amstelveen , NL

Entity Type: 03

Trademark Details

Filing Date

June 3, 2004

Registration Date

May 8, 2007

Published for Opposition

May 9, 2006

Cancellation Date

December 13, 2013

Goods & Services

Pharmaceutical preparations for treating cardiovascular diseases, namely, ischemic heart diseases, cardiac insufficiency, hypertension, arrhythmias, thrombosis, atherosclerosis, peripheral arterial disease, restenosis, and shock resuscitation; venous disorders, namely, deep venous thrombosis; cerebral diseases, namely, stroke, neurodegenerative pathologies, Alzheimer's disease, Parkinson's disease, sleep pathologies, depression, anxiousness, psychotic disorders, epilepsy, migraine headaches; inflammatory diseases, namely, osteoarthritis, rheumatoid arthritis, alkylosing spondylitis, tendonitis, acute gout, inflammatory bowel diseases, prostates, dysmenorrhoea, post-traumatic oedema, fever, cancer, colorectal cancer, ovarian cancer, breast carcinoma, leukemia, prostate cancer, neuroblastoma, apoptosis processes, cancer cachexia syndrome; inhibiting tumor cell growth; for use as chemotherapy efficacy enhancers; immune diseases induced by virus, namely, herpes, herpes zoster and Aids; diabetes, cholesterol and lipid disorders; eye disease, retina ischemic, retina degeneration, glaucoma, and dry eye; sexual dysfunction, angiogenesis, inner ear disease, neuropathic pain, pain during anaesthesia, pulmonary diseases, cystic fibrosis, pulmonary hypertension, exocrine gland disease; antiseptic preparations; dietary food supplements; animal feed additive for use as a nutritional supplement; and dressings for wounds, burns and surgical use

Filing History

CANCELLED SEC. 8 (6-YR)
Dec 13, 2013 C8..
REGISTERED-PRINCIPAL REGISTER
May 8, 2007 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Mar 6, 2007 DP1B
NOTICE OF ALLOWANCE CANCELLED
Jan 29, 2007 IUCN
PAPER RECEIVED
Jan 29, 2007 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
Aug 1, 2006 NOAM
PUBLISHED FOR OPPOSITION
May 9, 2006 PUBO
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 3, 2006 ASCK
NOTICE OF PUBLICATION
Apr 19, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 20, 2006 PREV
ASSIGNED TO LIE
Mar 17, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 2006 CNSA
AMENDMENT FROM APPLICANT ENTERED
Mar 7, 2006 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2006 CRFA
PAPER RECEIVED
Feb 17, 2006 MAIL
INQUIRY AS TO SUSPENSION MAILED
Feb 17, 2006 CNSI
SUSPENSION INQUIRY WRITTEN
Feb 16, 2006 CNSI
LETTER OF SUSPENSION MAILED
Aug 1, 2005 CNSL
SUSPENSION LETTER WRITTEN
Jul 30, 2005 CNSL
AMENDMENT FROM APPLICANT ENTERED
Jul 1, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 27, 2005 CRFA
PAPER RECEIVED
Jun 27, 2005 MAIL
NON-FINAL ACTION MAILED
Jan 6, 2005 CNRT
NON-FINAL ACTION WRITTEN
Jan 5, 2005 CNRT
ASSIGNED TO EXAMINER
Jan 5, 2005 DOCK
NEW APPLICATION ENTERED
Jun 17, 2004 NWAP